English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  50423008    Online Users :  908
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 235551-235575 of 2347236  (93890 Page(s) Totally)
<< < 9418 9419 9420 9421 9422 9423 9424 9425 9426 9427 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2019 Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC) Yang P.-W.;Liu Y.-C.;Chang Y.-H.;Lin C.-C.;Huang P.-M.;Hua K.-T.;Jang-Ming Lee;Hsieh M.-S.; Yang P.-W.; Liu Y.-C.; Chang Y.-H.; Lin C.-C.; Huang P.-M.; Hua K.-T.; JANG-MING LEE; Hsieh M.-S.
臺大學術典藏 2019 Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC) Yang P.-W.;Liu Y.-C.;Chang Y.-H.;Lin C.-C.;Pei-Ming Huang;Hua K.-T.;Lee J.-M.;Hsieh M.-S.; Yang P.-W.; Liu Y.-C.; Chang Y.-H.; Lin C.-C.; PEI-MING HUANG; Hua K.-T.; Lee J.-M.; Hsieh M.-S.
臺大學術典藏 2020-03-05T08:03:56Z Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC) Yang P.-W.;Liu Y.-C.;Chang Y.-H.;Lin C.-C.;Huang P.-M.;Hua K.-T.;Lee J.-M.;Min-Shu Hsieh; Yang P.-W.; Liu Y.-C.; Chang Y.-H.; Lin C.-C.; Huang P.-M.; Hua K.-T.; Lee J.-M.; MIN-SHU HSIEH
臺大學術典藏 2021-05-27T08:09:47Z Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC) Yang P.-W.;Liu Y.-C.;Chang Y.-H.;Lin C.-C.;Huang P.-M.;Kuo-Tai Hua;Lee J.-M.;Hsieh M.-S.; Yang P.-W.; Liu Y.-C.; Chang Y.-H.; Lin C.-C.; Huang P.-M.; KUO-TAI HUA; Lee J.-M.; Hsieh M.-S.
臺大學術典藏 2021-08-22T00:00:08Z Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial Brose, Marcia S.; Robinson, Bruce; Sherman, Steven I.; Krajewska, Jolanta; Chia-Chi Lin; Vaisman, Fernanda; Hoff, Ana O.; Hitre, Erika; Bowles, Daniel W.; Hernando, Jorge; Faoro, Leonardo; Banerjee, Kamalika; Oliver, Jennifer W.; Keam, Bhumsuk; Capdevila, Jaume
臺大學術典藏 2022-09-15T01:08:47Z Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial Brose M.S.; Robinson B.; Sherman S.I.; Krajewska J.; Chia-Chi Lin; Vaisman F.; Hoff A.O.; Hitre E.; Bowles D.W.; Hernando J.; Faoro L.; Banerjee K.; Oliver J.W.; Keam B.; Capdevila J.
臺大學術典藏 2021-08-31T06:29:16Z Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design Kelley R.K.; W Oliver J.; Hazra S.; Benzaghou F.; Yau T.; ANN-LII CHENG; Rimassa L.
臺大學術典藏 2021-08-31T06:29:27Z Cabozantinib in patients with advanced and progressing hepatocellular carcinoma Abou-Alfa G.K.; Meyer T.; ANN-LII CHENG; El-Khoueiry A.B.; Rimassa L.; Ryoo B.-Y.; Cicin I.; Merle P.; Chen Y.; Park J.-W.; Blanc J.-F.; Bolondi L.; Kl?mpen H.-J.; Chan S.L.; Zagonel V.; Pressiani T.; Ryu M.-H.; Venook A.P.; Hessel C.; Borgman-Hagey A.E.; Schwab G.; Kelley R.K.
臺大學術典藏 2020-05-25T07:35:26Z Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial Smith D.C; Smith M.R; Sweeney C; Elfiky A.A; Logothetis C; Corn P.G; Vogelzang N.J; Small E.J; Harzstark A.L; Gordon M.S; Vaishampayan U.N; Haas N.B; Spira A.I; Lara Jr. P.N; Chia-Chi Lin; Srinivas S; Sella A; Sch?ffski P; Scheffold C; Weitzman A.L; Hussain M.
國立臺灣大學 2016 Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) Lu, Jeng-Wei; Wang, An-Ni; Liao, Heng-An; Chen, Chien-Yuan; Hou, Hsin-An; Hu, Chung-Yi; Tien, Hwei-Fan; Ou, Da-Liang; Lin, Liang-In; 林亮音; 陳建源; 田蕙芬; 胡忠怡; 侯信安
臺大學術典藏 2020-07-03T08:45:43Z Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) Lu J.-W;Wang A.-N;Liao H.-A;Chen C.-Y;Hou H.-A;Hu C.-Y;Tien H.-F;Da-Liang Ou;Lin L.-I.; Lu J.-W; Wang A.-N; Liao H.-A; Chen C.-Y; Hou H.-A; Hu C.-Y; Tien H.-F; DA-LIANG OU; Lin L.-I.
臺大學術典藏 2021-03-15T07:59:41Z Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) Lu J.-W.;Wang A.-N.;Liao H.-A.;Chen C.-Y.;Hou H.-A.;Chung-Yi Hu;Tien H.-F.;Ou D.-L.;Lin L.-I.; Lu J.-W.; Wang A.-N.; Liao H.-A.; Chen C.-Y.; Hou H.-A.; CHUNG-YI HU; Tien H.-F.; Ou D.-L.; Lin L.-I.
臺大學術典藏 2021-01-04T12:12:28Z Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) Wang A.-N.; Lu J.-W.; Lin L.-I.; Ou D.-L.; HWEI-FANG TIEN; Hu C.-Y.; Hou H.-A.; Liao H.-A.; Chen C.-Y.
臺大學術典藏 2022-01-12T07:07:25Z Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) Lu J.-W.; Wang A.-N.; Liao H.-A.; Chen C.-Y.; HSIN-AN HOU; Hu C.-Y.; Tien H.-F.; Ou D.-L.; Lin L.-I.
國立臺灣大學 2014 CABOZANTINIB IS SELECTIVELY CYTOTOXIC IN ACUTE MYELOID LEUKEMIA CELLS WITH INTERNAL TANDEM DUPLICATION OF FLT3 (FLT3-ITD) Wang, A.; Lu, J. W.; Hou, H. A.; Chen, C. Y.; Hu, C. Y.; Ou, D. L.; Ko, Y. C.; Tien, H. F.; Lin, L. I.; 林亮音; 陳建源; 田蕙芬; 胡忠怡; 侯信安
臺大學術典藏 2021-07-06T01:54:58Z Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation Fu, Yu-Hsuan; Ou, Da-Liang; Yang, Yi-Ru; Su, Kuan-Wei; Tien, Hwei-Fan; Lai, Zheng-Sheng; Shen, Che-Kun James; Chien, Hsiung-Fei; Chen, Chien-Yuan; LIANG-IN LIN
臺大學術典藏 2021-07-15T05:31:41Z Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation Fu, Yu Hsuan; DA-LIANG OU; Yang, Yi Ru; Su, Kuan Wei; Chen, Chien-Yuan; Tien, Hwei Fan; Lai, Zheng Sheng; Shen, Che Kun James; HSIUNG-FEI CHIEN; LIANG-IN LIN
臺大學術典藏 2022-02-08T06:27:20Z Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation Fu Y.-H.; DA-LIANG OU; Yang Y.-R.; Su K.-W.; Chen C.-Y.; Tien H.-F.; Lai Z.-S.; Shen C.-K.J.; Chien H.-F.; Lin L.-I.
臺大學術典藏 2022-01-25T05:59:47Z Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation Fu, Yu-Hsuan; Ou, Da-Liang; Yang, Yi-Ru; Su, Kuan-Wei; Chen, Chien-Yuan; HWEI-FANG TIEN; Lai, Zheng-Sheng; Shen, Che-Kun James; Chien, Hsiung-Fei; Lin, Liang-In
國立政治大學 2006-06 CAC and Packet Scheduling Using Token Bucket for IEEE 802.16 Networks 蔡子傑; Tsai,Tzu-Chieh; Chuang-Yin Wang; Chi-Hong Jiang
國立高雄大學 2012-02-29 Các phố nghề ở Hà Nội 阮氏美香
國立高雄大學 2012-02-29 Các triều đại Việt Nam 阮氏美香
國立臺灣師範大學 2014-10-27T15:07:55Z CAC 的概念及其實踐 寺田文行; 邱日盛 譯
國立臺灣師範大學 2014-10-27T15:08:42Z CAC 的構想 寺田文行; 邱日盛 譯
國立臺灣師範大學 2014-10-27T15:08:42Z CAC 的構想 寺田文行; 邱日盛 譯

Showing items 235551-235575 of 2347236  (93890 Page(s) Totally)
<< < 9418 9419 9420 9421 9422 9423 9424 9425 9426 9427 > >>
View [10|25|50] records per page